-
October 22: The Week in Cancer News
Researchers suggest Black women should be screened for breast cancer at age 40, and a couple reflect on how a cancer diagnosis affected their adoption journey.
by Bradley Jones
-
October 8: The Week in Cancer News
A study shows the cost of drugs that manage cancer-related symptoms adds up, and experts explore research at the AACR conference on cancer disparities.
by Marci A. Landsmann
-
October 1: The Week in Cancer News
MRI can be a cost-effective way to screen for breast cancer, and a new study investigates the impact of higher alcohol taxes on cancer incidence
by Kevin McLaughlin
-
Risk in the Air
Air pollution can increase a person's risk of developing cancer, a burden that isn't shared equally in every neighborhood.
by Jon Kelvey
-
Forward Look
Spotlight on Small Cell Lung CancerTreatments for small cell lung cancer have remained virtually the same for decades. Now, experts say that hope is on the horizon.
by Isobel Whitcomb
-
Rethinking Clinical Trials
Could changes spurred by safety concerns during the pandemic make clinical trials more accessible to patients?
by Charlotte Huff
-
Facts and Stats
Looking Closely at Lung CancerWhile there are many kinds of lung cancer, screening recommendations are standard across the board.
by Bradley Jones
-
Healthy Habits
An Alternative to MeatAre new plant-based meat alternatives a better way to satisfy burger cravings?
by Erin O’Donnell
-
Forward Look
New Treatment Approved for Lung CancerKRAS mutations were once thought to be resistant to drug therapy.
by Carisa Brewster
-
Forward Look
Predicting Colorectal Cancer RecurrenceLiquid biopsy tests can find tiny amounts of disease that remain after surgery and chemotherapy.
by Kris Conner
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff